申请人:CURADEV PHARMA PRIVATE LTD.
公开号:US10294212B2
公开(公告)日:2019-05-21
The present application provides novel inhibitors of indoleamine 2,3-dioxygenase-1 and/or indoleamine 2,3-dioxygenase-2 and/or tryptophan 2,3-dioxygenase, metabolites thereof, and pharmaceutically acceptable salts or prodrugs thereof. Also provided are methods for preparing these compounds. A therapeutically effective amount of one or more of the compounds of formula (I) is useful in treating diseases resulting from dysregulation of the kynurenine pathway. Compounds of formula (I) act by inhibiting the enzymatic activity or expression of indoleamine 2,3-dioxygenase-1 and/or indoleamine 2,3-dioxygenase-2 and/or tryptophan 2,3-dioxy-genase.
本申请提供了吲哚胺 2,3-二氧合酶-1和/或吲哚胺 2,3-二氧合酶-2和/或色氨酸 2,3-二氧合酶的新型抑制剂、其代谢物及其药学上可接受的盐或原药。还提供了制备这些化合物的方法。治疗有效量的一种或多种式(I)化合物可用于治疗犬尿氨酸途径失调引起的疾病。式(I)化合物通过抑制吲哚胺 2,3-二氧合酶-1 和/或吲哚胺 2,3-二氧合酶-2 和/或色氨酸 2,3-二氧合酶的酶活性或表达发挥作用。